1 Min Read
* Says its Jilin-based controlling bio-tech unit plans to buy 100 percent stake in a Changchun-based pharma tech company for 3 million yuan
Source text in Chinese: goo.gl/9yzYBU
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.